We advised the underwriter in the SPAC IPO and Nasdaq listing

Davis Polk advised the underwriter, in connection with the initial public offering of 31,050,000 units of Science Strategic Acquisition Corp. Alpha (“Science Strategic”), including 4,050,000 units purchased pursuant to the full exercise of the underwriter’s option to purchase additional units, for aggregate proceeds of $310.5 million. Each unit consists of one share of Class A common stock and one-third of one warrant to purchase one share of Class A common stock. The Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “SSAA” and “SSAAW,” respectively.

Science Strategic is a newly incorporated special acquisition company (SPAC), incorporated as a Delaware corporation for the purpose of effecting a business combination with one or more businesses. The SPAC is led by the founders of Science Inc., a data-driven investment firm focused on investment opportunities driven by shifting consumer behaviors and the technologies that enable them. Science Strategic intends to focus on direct-to-consumer brands, direct-to-consumer services and marketplaces, and mobile and social entertainment.

The Davis Polk corporate team included partners Derek Dostal and Deanna L. Kirkpatrick and associates Eryn E. Gordon and Genevieve A. Lewis. The tax team included partner Lucy W. Farr and associate Tomislava Dragicevic. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the New York and Washington DC offices.